Who are Soley's investors?

Soley's investors include Artisanal Ventures, Breyer Capital.

How much funding has Soley raised?

Soley has disclosed $20M raised across 1 round.

Where is Soley headquartered?

Soley is headquartered in South San Francisco, US.

Soley

South San Francisco, US · Founded 2020 · Delaware corporation · 42 employees on LinkedIn · 2 known investors

Find your way into Soley

Paths you didn't know you had: your email and LinkedIn already hold routes to the Soley team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Soley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Ken V. AlwynChief Financial Officer

Kurosh AmeriNamed on SEC filing

Yerem YeghiazariansNamed on SEC filing

Investors · 2

Artisanal Ventureslisted by Artisanal VenturesTiburon

How we know: Artisanal Ventures's portfolio page · Not right? Tell us

Breyer Capitallisted by Breyer CapitalAustin · $500K – $10M

How we know: Breyer Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2020

▶$20MraisedDec 2020 · 32 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Kurosh AmeriDirector
Yerem YeghiazariansDirector
Ken V. AlwynExecutive Officer, Director

Offering amount: $20M
Amount sold: $20M
First sale: Oct 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

SoluSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.

Applied TherapeuticsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.

Kite PharmaKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.

Companies working in the same space as Soley.

Frequently asked questions

What does Soley do?: Soley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.
Who are Soley's investors?: Soley's investors include Artisanal Ventures, Breyer Capital.
How much funding has Soley raised?: Soley has disclosed $20M raised across 1 round.
Where is Soley headquartered?: Soley is headquartered in South San Francisco, US.